Tag

#IndiaPharma

Explore articles tagged with IndiaPharma

Active Filters:
Tag: IndiaPharma
Clear All
India’s Race for the CDMO Crown | Express Pharma
Industry News

India’s Race for the CDMO Crown | Express Pharma

HRV Pharma Founder, MD & CEO Hari Kiran Chereddi shares insights in Express Pharma on India’s opportunity to become a strategic global CDMO partner through specialised capabilities, regulatory strength, scientific expertise and reliable execution.

The New Growth Blueprint for APIs | BW Healthcare World
Industry News

The New Growth Blueprint for APIs | BW Healthcare World

The API industry is rethinking how manufacturing capacity and supply chains are structured, with manufacturing networks offering a more resilient approach through qualified partners, regulatory ownership and greater visibility.

One System for Both Sides of Pharma
Artificial Intelligence

One System for Both Sides of Pharma

HRV Pharma's RIKO is designed to bridge the gap between pharmaceutical manufacturers and customers. Drawing on millions of proprietary decisions across 55 countries, the AI-native platform supports faster partner qualification, transparent enquiry matching and early risk assessment across the pharmaceutical value chain.

Catching Risk Before It Becomes a Recall
Artificial Intelligence

Catching Risk Before It Becomes a Recall

In the pharmaceutical industry, identifying risks early can help prevent costly quality failures and recalls. PharmaClick explores how HRV Pharma's RIKO platform uses AI-driven pharmaceutical intelligence to assess chemistry risks, nitrosamine potential, supplier reliability and regulatory history before commitments are made.

What Indian Pharma Is Really Buying
Business & Growth

What Indian Pharma Is Really Buying

Sun Pharma's $11.75 billion acquisition of Organon highlights a broader shift in the Indian pharmaceutical industry. Featuring insights from industry leaders, including HRV Pharma's Hari Kiran Chereddi, BioSpectrum explores the growing importance of brand value, specialty portfolios, biosimilars and access to regulated global markets.

Why the Future of Drug Development Begins Before Manufacturing
Industry News

Why the Future of Drug Development Begins Before Manufacturing

HRV Pharma CEO Hari Kiran Chereddi explains why drug development success is now determined before manufacturing, driven by data, predictive analytics, and strategic decision-making.

Future of Pharma: From Factories to Platform-Driven Models
Industry News

Future of Pharma: From Factories to Platform-Driven Models

HRV Pharma CEO Hari Kiran Chereddi shares insights on how platform-driven models are transforming pharma from factory-led systems to intelligent, network-based ecosystems.

From Supply Chain Risk to Supply Chain Advantage: How Indian CDMOs Are Reshaping Global Pharma
Industry News

From Supply Chain Risk to Supply Chain Advantage: How Indian CDMOs Are Reshaping Global Pharma

HRV Pharma MD & CEO Hari Kiran Chereddi shares insights on how Indian CDMOs are transforming global pharmaceutical supply chains from risk-driven models to resilient, flexible, and strategic advantage.

HRV Pharma Partners with Shodhana Laboratories to Accelerate Next-Gen API Development
Industry News

HRV Pharma Partners with Shodhana Laboratories to Accelerate Next-Gen API Development

HRV Pharma partners with Shodhana Laboratories to accelerate next-generation API development, combining AI-enabled virtual manufacturing with precision chemistry and global regulatory execution.

HRV Pharma Honoured at ET RE-Pharma Awards 2026 for Excellence in Pharma Global Business Support
Industry News

HRV Pharma Honoured at ET RE-Pharma Awards 2026 for Excellence in Pharma Global Business Support

HRV Pharma (Group) has been recognised at the ET RE-Pharma Awards 2026 for Excellence in Pharma Global Business Support, highlighting its leadership in compliant, agile, and globally integrated pharmaceutical operations.

Why API Self-Reliance Is Back at the Centre of India’s Pharma Strategy
Industry News

Why API Self-Reliance Is Back at the Centre of India’s Pharma Strategy

In BW Healthcare World, HRV Pharma MD & CEO Hari Kiran Chereddi outlines why API self-reliance has re-emerged as a strategic priority under Biopharma SHAKTI and what it means for India’s pharmaceutical future.

Union Budget 2026–27: Strengthening India’s Biopharma Ecosystem and Healthcare Access
Industry News

Union Budget 2026–27: Strengthening India’s Biopharma Ecosystem and Healthcare Access

HRV Pharma CEO Hari Kiran Chereddi shares his insights on how Union Budget 2026–27’s focus on biopharma innovation, affordable cancer care, and healthcare infrastructure will shape India’s pharmaceutical future.

How Virtual Manufacturing Is Solving Structural Causes of Global Drug Shortages
Industry News

How Virtual Manufacturing Is Solving Structural Causes of Global Drug Shortages

Virtual pharmaceutical manufacturing models are helping solve structural drug shortages by connecting global GMP capacity, improving supply flexibility, and strengthening regulatory execution.

HRV Pharma Partners with Haleos Labs to Accelerate Orphan and Niche API Development
Industry News

HRV Pharma Partners with Haleos Labs to Accelerate Orphan and Niche API Development

HRV Pharma has entered a multi‑year strategic partnership with Haleos Labs to accelerate the development and manufacture of orphan and niche APIs, strengthening global access to complex therapies for rare diseases.

How HRV Pharma’s Virtual Model Helps Solve America’s Drug Shortage Crisis
Industry News

How HRV Pharma’s Virtual Model Helps Solve America’s Drug Shortage Crisis

HRV Pharma’s capital‑efficient virtual pharmaceutical model is helping address America’s drug shortage crisis by linking underutilized global manufacturing capacity with regulatory strength to ensure consistent API supply.

HRV Pharma Redefines India’s Bulk Drug Business with a Virtual Pharma Model
Industry News

HRV Pharma Redefines India’s Bulk Drug Business with a Virtual Pharma Model

Fortune India features HRV Pharma for pioneering a capital‑efficient virtual pharma model that is transforming India’s bulk drug and API ecosystem through speed, compliance, and global regulatory execution.

Indian Biosimilars on the Global Stage: HRV Pharma CEO's Insights in Express Pharma
Industry News

Indian Biosimilars on the Global Stage: HRV Pharma CEO's Insights in Express Pharma

India's rise in biosimilars & biologics. Full clipping + insights included.